Company Number: 13728933

Analysis Date: 2025-07-20 14:59 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   JAKS NURSERY LIMITED demonstrates improving financial health with growing net assets and net current assets over the last two years, indicating enhanced ability to service debt. However, the company remains relatively young (incorporated late 2021) with limited trading history. The presence of director loans totaling £24,000 raises a note of caution as this may indicate reliance on related-party funding rather than external credit. Continued monitoring of profitability and creditor management is recommended before extending significant credit facilities.

2. Financial Strength:

• Net assets increased substantially from £6,960 in 2022 to £44,476 in 2023, reflecting retained earnings growth (£44,376 Profit & Loss reserve vs. £6,860 prior year).
• Tangible fixed assets remain modest (£4,599) and do not pose significant collateral value but show some investment in plant and equipment.
• Current assets (£54,806) comfortably exceed current liabilities (£11,801), producing strong net working capital of £43,005, indicating good short-term financial stability.
• Long-term creditors reduced from £16,128 in 2022 to £3,128 in 2023, improving overall solvency.

3. Cash Flow Assessment:

• Cash balance improved to £28,588 (2023) from £18,535 (2022), supporting liquidity and operational cash flow.
• Debtors increased significantly from £971 to £26,218, which may reflect business growth but requires scrutiny of debtor aging to assess collection risk.
• The company has positive net current assets, indicating sufficient liquidity to meet short-term obligations without stress.
• The reliance on director loans (£24,000) is notable and should be reviewed in terms of repayment plans and any impact on liquidity.

4. Monitoring Points:

• Debtor collection efficiency and aging profile to ensure receivables are converted timely into cash.
• Profitability trends and cash flow from operations to confirm that earnings support sustainable growth.
• Director loans usage and repayment schedule to evaluate related-party funding risks.
• Creditors management, particularly taxes and social security liabilities which have increased markedly, to avoid payment defaults.
• Business performance resilience amid economic uncertainties given the company’s early stage and sector classification in business support services.